RecruitingNot ApplicableNCT06904495

Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age


Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment

400 participants

Start Date

Apr 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications. In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.


Eligibility

Min Age: 15 YearsMax Age: 24 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Survey of sleep quality and associated factors for people with cancer survivors. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSurvey of sleep quality and associated factors

Sleep quality and associated factors (anxiety, depression, and pain) will be evaluated through an online survey on the Reseau Morphee platform, through an self-administered evaluation of the patients' pain and sleep difficulties, and a precarity scale.


Locations(1)

CHU de Nice

Nice, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06904495


Related Trials